Quantitative autoradiographic mapping of focal herpes simplex vi

Details Quantitative autoradiographic mapping of focal herpes simplex vi Quantitative autoradiographic mapping of focal herpes simplex vi

1982-09-15

1984-12-18

Nucker, Christine M.

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

424 9, 536 23, A61K 4300, A61K 4900

Patent

active

044890524

ABSTRACT:
A method of mapping herpes simplex viral infection comprising administering a radiolabeled antiviral active 5-substituted 1-(2'-deoxy-2'-substituted-D-arabinofuranosyl) pyrimidine nucleoside to the infected subject, and scanning the area in which the infection is to be mapped for the radiolabel.

REFERENCES:
patent: 4341754 (1982-07-01), Kaplan et al.
Fong et al., J. of Virology, vol. 34, (1980), 644-649.
Tuckes et al., Chem. Abstracts, vol. 95 (1981), #86254g.
Boorstein et al., Chem. Abstracts, vol. 98 (1983), #194521n.
Dundarov et al., Chem. Abstracts, vol. 76 (1972), #23591b.
Machida et al., Antimicrob. Agents Chemother., vol. 17 (1980), 109-114.
Saito et al., Science, vol. 217 (1982), 1151-1153.

Affiliated with

Also associated with

Rating

Quantitative autoradiographic mapping of focal herpes simplex vi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quantitative autoradiographic mapping of focal herpes simplex vi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quantitative autoradiographic mapping of focal herpes simplex vi will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1988142